Colonic Polyps
Conditions
Brief summary
The ClearCoajet is a new hemostasis device with a hybrid function (Coagulation + Injection) and is developed to provide effective coagulation, injection, and marking around lesions without changing devices during the endoscopic procedure. In this study, the investigators examine the hemostatic effect of ClearCoajet on intraprocedural bleeding during endoscopic mucosal resection or endoscopic submucosal dissection for colorectal sessile polyps or lateral growth tumors larger than 1.5 cm. The investigators also aim to compare the delayed bleeding and recurrence rates between the ClearCoajet group and the control group.
Interventions
The ClearCoajet is a new hemostasis device with a hybrid function (Coagulation + Injection) and is developed to provide effective coagulation, injection, and marking around lesions without changing devices during the endoscopic procedure.
Sponsors
Study design
Eligibility
Inclusion criteria
* patients with colorectal sessile polyps or lateral growth tumors larger than 1.5 cm
Exclusion criteria
* Pedunculated polyp * Patients with coagulopathy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hemostasis of intraprocedural bleeding | during endoscopic resection for colorectal lesions | Hemostasis efficacy of intraprocedural bleeding during endoscopic resection for colorectal lesions |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Delayed bleeding rate | within 4 weeks after endoscopic resection | Delayed bleeding rate within 4 weeks after endoscopic resection |
| Complication rate | within 4 weeks after endoscopic resection | Complication rate |
Countries
South Korea